Marval Biosciences' Series C Round

Marval Biosciences raised a round of funding on July 26, 2012.

Marval Biosciences is an early stage company, developing contrast agents for use in X-ray and Computed Tomography (CT) Imaging. Marval's lead candidate, NCTX, targets cardiovascular imaging.…

Articles about Marval Biosciences' Series C Round: